Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.
暂无分享，去创建一个
J. Sanz | J. Badimón | P. Moreno | G. Escolar | A. Lala | J. Contreras | S. Lerakis | N. Moss | C. Santos-Gallego | S. Mitter | David W Lam | V. Abascal | I. Fergus | Farah Atallah-Lajam | J. A. Requena-Ibáñez | J. Rodríguez-Capitán | D. Mancini | Valentín Fuster | M. Urooj Zafar | Maeve Soto Pérez